Quality of life in inflammatory bowel diseases: it is not all about the bowel

Ronald Keller1, Nazar Mazurak2, Laura Fantasia1

  • 1Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.

Intestinal Research
|February 26, 2020
PubMed

Insights

Inflammatory bowel diseases (IBD) significantly impair quality of life (QUOL). Extraintestinal manifestations, smoking, and psychological factors negatively impact QUOL, while ostomies may improve it, especially in Crohn's disease (CD).

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Patient-Reported Outcomes

Background:

  • Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic conditions predominantly affecting young individuals.
  • Quality of life (QUOL) is intrinsically linked to disease activity and is a crucial therapeutic target for lifelong conditions.
  • Identifying factors influencing QUOL is essential for optimizing patient management and treatment strategies.

Purpose of the Study:

  • To identify key factors contributing to either good or impaired health-related quality of life (HR-QUOL) in patients with IBD.
  • To assess the impact of various clinical, psychological, and social factors on the HR-QUOL of UC and CD patients.

Main Methods:

  • A cross-sectional study utilizing online questionnaires distributed via institutional and IBD self-help group webpages in Germany.
  • Patients were categorized based on HR-QUOL scores (cutoff <60) using validated instruments: Short Inflammatory Bowel Disease Questionnaire, Assessment of the Demand for Additional Psychological Treatment, and Fear of Progression Questionnaire Short Form.

Main Results:

  • A high prevalence of impaired HR-QUOL was observed: 87.34% in UC and 91.08% in CD patients.
  • Factors associated with reduced HR-QUOL included active extraintestinal manifestations, smoking, high fear of progression, and a high demand for psychotherapy.
  • Polypharmacological treatments did not correlate with good HR-QUOL, whereas ostomies were linked to improved HR-QUOL, particularly in CD patients.

Conclusions:

  • Current clinical assessments focusing primarily on somatic factors are insufficient for comprehensively evaluating patient QUOL in IBD.
  • Extraintestinal manifestations represent a significant, often underestimated, determinant of impaired QUOL in inflammatory bowel diseases.
  • Psychological and social factors play a critical role in the overall well-being of IBD patients, necessitating integrated care approaches.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
850
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
699
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
386
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
776
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
367